Sharon Larkin Biography and Net Worth

Director of Senseonics


Ms. Larkin was appointed to our Board of Directors in December 2021. Ms. Larkin is a former senior executive of Assertio Therapeutics, Inc., having retired in 2020 as senior vice president, Human Resources and Administration. Ms. Larkin joined Assertio Therapeutics, Inc., in 2017 after retiring from Abbott as divisional vice president, Human Resources, Medical Devices Group, where she provided global human resources leadership for Abbott’s five medical device operating businesses, including Abbott Diabetes Care, Abbott Vascular, Abbott Medical Optics, Abbott Animal Health and Abbott Electrophysiology. Ms. Larkin joined Abbott in 1992 and also held positions of increased responsibility in Abbott’s Nutrition, HealthSystems and Corporate operations. Prior to joining Abbott, Ms. Larkin worked for the Federal Reserve Bank of Atlanta, Jacksonville Branch, where she provided leadership for the branch’s U.S. Treasury securities services and human resources operations. Ms. Larkin received a B.S. in industrial management from the Georgia Institute of Technology.

What is Sharon D. Larkin's net worth?

The estimated net worth of Sharon D. Larkin is at least $98.41 thousand as of September 7th, 2023. Ms. Larkin owns 14,623 shares of Senseonics stock worth more than $98,413 as of December 4th. This net worth estimate does not reflect any other investments that Ms. Larkin may own. Learn More about Sharon D. Larkin's net worth.

How do I contact Sharon D. Larkin?

The corporate mailing address for Ms. Larkin and other Senseonics executives is 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, United States. Senseonics can also be reached via phone at 301-515-7260 and via email at [email protected]. Learn More on Sharon D. Larkin's contact information.

Has Sharon D. Larkin been buying or selling shares of Senseonics?

Sharon D. Larkin has not been actively trading shares of Senseonics over the course of the past ninety days. Most recently, Sharon Larkin sold 1,544 shares of the business's stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $12.20, for a transaction totalling $18,836.80. Following the completion of the sale, the director now directly owns 14,623 shares of the company's stock, valued at $178,400.60. Learn More on Sharon D. Larkin's trading history.

Who are Senseonics' active insiders?

Senseonics' insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), and Frederick Sullivan (CFO). Learn More on Senseonics' active insiders.

Are insiders buying or selling shares of Senseonics?

During the last twelve months, Senseonics insiders bought shares 5 times. They purchased a total of 52,411 shares worth more than $329,909.80. The most recent insider tranaction occured on November, 10th when Director Edelman Steven bought 10,000 shares worth more than $65,500.00. Insiders at Senseonics own 3.6% of the company. Learn More about insider trades at Senseonics.

Information on this page was last updated on 11/10/2025.

Sharon D. Larkin Insider Trading History at Senseonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2023Sell1,544$12.20$18,836.8014,623View SEC Filing Icon  
See Full Table

Sharon D. Larkin Buying and Selling Activity at Senseonics

This chart shows Sharon Larkin's buying and selling at Senseonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senseonics Company Overview

Senseonics logo
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.73
Low: $6.30
High: $6.89

50 Day Range

MA: $7.28
Low: $5.27
High: $11.30

2 Week Range

Now: $6.73
Low: $5.00
High: $28.00

Volume

366,949 shs

Average Volume

424,521 shs

Market Capitalization

$274.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92